Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
- Product NDC
- 70518-1648
- 11-digit product format
- 705181648
- Labeler code
- 70518
- Product ID
- 70518-1648_e5bcf9ee-e1b7-bc16-e053-2995a90ab299
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA200175
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2018-11-07
- Marketing end
- 2024-06-30
- Substance
- AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- Active strength
- 5 mg/1; mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1648-0 | 70518164800 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-1648-0) | 2018-11-07 | 0000-00-00 | No | No | Current |